QUANTITATIVE ANALYSIS OF IMMUNITY TO VIRAL IMMUNOGENS

病毒感染是老年人的重要病原体。免疫反应在保护个体免受病毒致命性感染方面发挥着重要作用。有证据表明，老年啮齿动物和人类的T细胞功能都受到了损害。我们的假设是，饮食限制(DR)可以防止因衰老而导致的营养不足。因此，我们将利用新颖的定量分析在相关的灵长类动物模型--恒河猴中检验这一假说。因此，我们将量化幼年对照(老年)和饮食受限(DR)猕猴接种疫苗后的细胞免疫反应。在过去五年的NIH支持下，我们增加了猕猴作为非人类灵长类动物模型的价值，通过定义主要组织相容性复合体(MHC)的等位基因和基因座，并开发基于序列的恒河猴MHC I和II类等位基因，来研究对重要人类病原体的免疫反应。我们还开发了病毒特异性细胞毒性T淋巴细胞(CTL)的分析技术，Altman博士开发了一种确定CTL前体频率的新技术。我们在测试有关衰老和DR对体内病毒感染的细胞免疫反应的影响的重要假说方面具有独特的优势。因此，我们将使用这些新技术来分析免疫猕猴的T细胞反应，以了解年龄和DR对病毒感染的细胞免疫反应的影响。由核心提供的独特的动物队列代表了一个宝贵的动物资源，这将使我们能够测试关于衰老和DR对灵长类动物在病毒感染中的免疫反应的作用的假设。在特定的目标I中，我们将描述10只健康的、MHC I类定义的年轻恒河猴对SIV的CD8+T细胞反应。这将导致至少4个新的免疫优势CTL表位与常见的恒河猴MHC I类分子结合。我们将利用这些表位构建特异靶II免疫原。在特异靶II中，我们将定量检测CD8+T细胞对CTL表位疫苗的应答。我们还将监测对乙肝病毒核心抗原的增殖反应和抗体反应。这将使我们能够评估衰老和DR对幼年动物、对照动物(老年动物)和受限动物CD8、CD4和B细胞室的影响。因此，在第1组、第2组和第3组动物的对照和受限队列中，我们将确定衰老是否会影响免疫反应，DR是否可以改变这一点。

Viral infections are important pathogens in the elderly. Immune response play a major role in protecting individuals from lethal infection with viruses. Evidence suggests that T cell function is compromised in both old rodents and humans. Our hypothesis is that dietary restriction (DR) can prevent the deficiencies induced by aging. We will, therefore, utilize novel, quantitative analyses to test this hypothesis in a relevant primate model, the rhesus macaque. Thus, we will quantitate the cellular immune response to vaccination in young, control (old) an dietary restricted (DR) rhesus macaques. Over the last five years of NIH support, we have increased the value of the rhesus macaque as a non-human primate model for studying the immune response to important human pathogens by defining the alleles and loci of the major histocompatibility complex (MHC) and developing sequence-based MHC typing of the rhesus-macaque MHC class I and II alleles. We have also developed technologies for the analysis of virus-specific cytotoxic T lymphocytes (CTLs) and Dr. Altman has developed a novel technology for determining CTL precursor frequencies. We are uniquely positioned to test important hypotheses concerning the effect of aging and DR on the cellular immune response to virus infection in vivo. We will, therefore, use these novel technologies for analyzing the T cell response in immunized rhesus macaques to understand the effects of age and DR on the cellular immune response to virus infection. The unique cohort of animals provided by the core represents an invaluable resource of animals that will allow us to test hypotheses concerning the role of aging and DR on the immune response of primates in virus infection. In Specific Aim I, we will describe the CD8+ T cell response to the simian immunodeficiency virus (SIV) in ten healthy, young MHC class I-defined rhesus macaques. This will result in the description of at least 4 new immunodominant CTL epitopes that bind to common rhesus MHC class I molecules. We will use these epitopes in the construction of immunogens in Specific Aim II. In Specific Aim II, we will quantitate the CD8+ T cell response to CTL epitope vaccination. We will also monitor the proliferative and antibody response to the hepatitis B virus (HBV) core antigen. This will allow us to assess the effect of aging and DR on the CD8, CD4 and B cell compartment in young, control (old) and restricted animals. In these control and restricted cohorts of animals in groups 1, 2 and 3 we will, therefore, determine whether aging can influence the immune response and whether DR can change this.